1. Home
  2. CPIX vs DALN Comparison

CPIX vs DALN Comparison

Compare CPIX & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • DALN
  • Stock Information
  • Founded
  • CPIX 1999
  • DALN 1954
  • Country
  • CPIX United States
  • DALN United States
  • Employees
  • CPIX N/A
  • DALN N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • DALN Newspapers/Magazines
  • Sector
  • CPIX Health Care
  • DALN Consumer Discretionary
  • Exchange
  • CPIX Nasdaq
  • DALN Nasdaq
  • Market Cap
  • CPIX 40.1M
  • DALN 38.1M
  • IPO Year
  • CPIX 2009
  • DALN 2008
  • Fundamental
  • Price
  • CPIX $3.15
  • DALN $4.42
  • Analyst Decision
  • CPIX
  • DALN
  • Analyst Count
  • CPIX 0
  • DALN 0
  • Target Price
  • CPIX N/A
  • DALN N/A
  • AVG Volume (30 Days)
  • CPIX 110.2K
  • DALN 38.9K
  • Earning Date
  • CPIX 08-05-2025
  • DALN 07-29-2025
  • Dividend Yield
  • CPIX N/A
  • DALN N/A
  • EPS Growth
  • CPIX N/A
  • DALN N/A
  • EPS
  • CPIX N/A
  • DALN 5.55
  • Revenue
  • CPIX $41,083,299.00
  • DALN $123,414,000.00
  • Revenue This Year
  • CPIX N/A
  • DALN N/A
  • Revenue Next Year
  • CPIX N/A
  • DALN N/A
  • P/E Ratio
  • CPIX N/A
  • DALN $0.80
  • Revenue Growth
  • CPIX 5.82
  • DALN N/A
  • 52 Week Low
  • CPIX $1.04
  • DALN $2.98
  • 52 Week High
  • CPIX $7.25
  • DALN $7.86
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 37.09
  • DALN 55.70
  • Support Level
  • CPIX $2.52
  • DALN $4.11
  • Resistance Level
  • CPIX $3.76
  • DALN $4.73
  • Average True Range (ATR)
  • CPIX 0.59
  • DALN 0.39
  • MACD
  • CPIX -0.14
  • DALN 0.05
  • Stochastic Oscillator
  • CPIX 19.39
  • DALN 50.00

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.

Share on Social Networks: